SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-066476
Filing Date
2023-08-14
Accepted
2023-08-14 07:30:07
Documents
14
Period of Report
2023-08-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183433-8k_gamida.htm   iXBRL 8-K 49288
2 PRESS RELEASE, DATED AUGUST 14, 2023 ea183433ex99-1_gamida.htm EX-99.1 97023
3 GRAPHIC ex99-1_001.jpg GRAPHIC 7272
  Complete submission text file 0001213900-23-066476.txt   348461

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE gmda-20230811.xsd EX-101.SCH 3024
5 XBRL LABEL FILE gmda-20230811_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE gmda-20230811_pre.xml EX-101.PRE 22365
8 EXTRACTED XBRL INSTANCE DOCUMENT ea183433-8k_gamida_htm.xml XML 3320
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38716 | Film No.: 231166262
SIC: 2836 Biological Products, (No Diagnostic Substances)